Medrobotics raises $20M to pursue FDA approval, EU marketing

Medrobotics, a surgical products company focused on medical robotics, raised $20 million in equity financing. The funds will be used to help extend the Medrobotics consumer market in Europe, where it has received CE marks for surgical tools, the Flex System and the Flex Retractor. The Flex System is designed for otolaryngology departments to perform minimally invasive head and neck surgeries. The startup is also gearing up for an expected FDA clearance which would allow it to market its products in the U.S. Release

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.